These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31302218)

  • 1. Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.
    Ghirardi L; Larsson H; Chang Z; Chen Q; Quinn PD; Hur K; Gibbons RD; D'Onofrio BM
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):944-951. PubMed ID: 31302218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.
    Ghirardi L; Chen Q; Chang Z; Kuja-Halkola R; Skoglund C; Quinn PD; D'Onofrio BM; Larsson H
    J Child Psychol Psychiatry; 2020 Feb; 61(2):140-147. PubMed ID: 31625605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: A Spoonful of Injury Prevention Makes the ADHD Medicine Go Down.
    Rockhill CM
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):920-922. PubMed ID: 31816419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.
    Chang Z; Quinn PD; Hur K; Gibbons RD; Sjölander A; Larsson H; D'Onofrio BM
    JAMA Psychiatry; 2017 Jun; 74(6):597-603. PubMed ID: 28492937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15-44 Years - United States, 2003-2015.
    Anderson KN; Ailes EC; Danielson M; Lind JN; Farr SL; Broussard CS; Tinker SC
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(2):66-70. PubMed ID: 29346342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
    Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
    Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD medications use and risk of mortality and unintentional injuries: a population-based cohort study.
    Vasiliadis HM; Lunghi C; Rahme E; Rochette L; Gignac M; Massamba V; Diallo FB; Fansi A; Cortese S; Lesage A
    Transl Psychiatry; 2024 Feb; 14(1):128. PubMed ID: 38418443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADHD Medication and Substance-Related Problems.
    Quinn PD; Chang Z; Hur K; Gibbons RD; Lahey BB; Rickert ME; Sjölander A; Lichtenstein P; Larsson H; D'Onofrio BM
    Am J Psychiatry; 2017 Sep; 174(9):877-885. PubMed ID: 28659039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
    Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
    N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder.
    van der Schans J; Pleiter JC; de Vries TW; Schuiling-Veninga CC; Bos JH; Hoekstra PJ; Hak E
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):186-91. PubMed ID: 27315741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I; Lee MS; Lee EK; Shin JY
    Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 28631372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
    Liman C; Schein J; Wu A; Huang X; Thadani S; Childress A; Kollins SH; Bhattacharjee S
    BMC Psychiatry; 2024 Sep; 24(1):618. PubMed ID: 39285361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of long-term ADHD medication use in Australian children.
    Efron D; Mulraney M; Sciberras E; Hiscock H; Hearps S; Coghill D
    Arch Dis Child; 2020 Jun; 105(6):593-597. PubMed ID: 31937570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004.
    Byrd HC; Curtin C; Anderson SE
    Pediatr Obes; 2013 Dec; 8(6):445-53. PubMed ID: 23325553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.